{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:54:17Z","timestamp":1791158057605,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T00:00:00Z","timestamp":1411171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00210-014-1048-3","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T02:57:47Z","timestamp":1411095467000},"page":"1187-1197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats"],"prefix":"10.1007","volume":"387","author":[{"given":"Heba","family":"Adel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Taye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M. A.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,20]]},"reference":[{"key":"1048_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2005.11.004","volume":"73","author":"M Ajay","year":"2006","unstructured":"Ajay M, Achike FI, Mustafa AM, Mustafa MR (2006) Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 73:1\u20137","journal-title":"Diabetes Res Clin Pract"},{"key":"1048_CR2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0735-1097(01)01729-6","volume":"39","author":"J Bauersachs","year":"2002","unstructured":"Bauersachs J, Heck M, Fraccarollo D, Hildemann SK, Ertl G, Wehling M, Christ M (2002) Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. J Am Coll Cardiol 39:351\u2013358","journal-title":"J Am Coll Cardiol"},{"key":"1048_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245\u2013313","journal-title":"Physiol Rev"},{"key":"1048_CR4","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.ATV.17.6.1152","volume":"17","author":"A Benetos","year":"1997","unstructured":"Benetos A, Lacolley P, Safar ME (1997) Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 17:1152\u20131156","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1048_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","volume":"52","author":"JA Buege","year":"1978","unstructured":"Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302\u2013310","journal-title":"Methods Enzymol"},{"key":"1048_CR6","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/sj.bjp.0703498","volume":"130","author":"H Buikema","year":"2000","unstructured":"Buikema H, Monnink SH, Tio RA, Crijns HJ, de Zeeuw D, van Gilst WH (2000) Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure. Br J Pharmacol 130:1999\u20132007","journal-title":"Br J Pharmacol"},{"key":"1048_CR7","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/db11-1243","volume":"61","author":"R Cangemi","year":"2012","unstructured":"Cangemi R, Pignatelli P, Carnevale R, Nigro C, Proietti M, Angelico F, Lauro D, Basili S, Violi F (2012) Platelet isoprostane overproduction in diabetic patients treated with aspirin. Diabetes 61:1626\u20131632","journal-title":"Diabetes"},{"key":"1048_CR8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1475-2840-13-88","volume":"13","author":"B Chen","year":"2014","unstructured":"Chen B, Zhao Q, Ni R, Tang F, Shan L, Cepinskas I, Cepinskas G, Wang W, Schiller PW, Peng T (2014) Inhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes. Cardiovasc Diabetol 13:88\u201399","journal-title":"Cardiovasc Diabetol"},{"key":"1048_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2013.09.028","volume":"721","author":"YS Cheng","year":"2013","unstructured":"Cheng YS, Dai DZ, Dai Y (2013) AQP4 KO exacerbating renal dysfunction is mediated by endoplasmic reticulum stress and p66Shc and is attenuated by apocynin and endothelin antagonist CPU0213. Eur J Pharmacol 721:249\u2013258","journal-title":"Eur J Pharmacol"},{"key":"1048_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.CIR.96.1.25","volume":"96","author":"F Cosentino","year":"1997","unstructured":"Cosentino F, Hishikawa K, Katusic ZS, Luscher TF (1997) High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25\u201328","journal-title":"Circulation"},{"key":"1048_CR11","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","volume":"108","author":"MA Creager","year":"2003","unstructured":"Creager MA, Luscher TF, Cosentino F, Beckman JA (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108:1527\u20131532","journal-title":"Circulation"},{"key":"1048_CR12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1464-410X.1997.00361.x","volume":"80","author":"R Dahiya","year":"1997","unstructured":"Dahiya R, Lin A, Bakircioglu ME, Huang ST, Lue TF (1997) mRNA and protein expression of nitric oxide synthase and adrenoceptor alpha 1 in young and old rat penile tissues. Br J Urol 80:300\u2013306","journal-title":"Br J Urol"},{"key":"1048_CR13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0008-6363(00)00035-3","volume":"46","author":"IM Dixon","year":"2000","unstructured":"Dixon IM, Hao J, Reid NL, Roth JC (2000) Effect of chronic AT(1) receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters. Cardiovasc Res 46:286\u2013297","journal-title":"Cardiovasc Res"},{"key":"1048_CR14","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1167\/iovs.02-1022","volume":"44","author":"AB El-Remessy","year":"2003","unstructured":"El-Remessy AB, Abou-Mohamed G, Caldwell RW, Caldwell RB (2003) High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci 44:3135\u20133143","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1048_CR15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","volume":"101","author":"CA Farquharson","year":"2000","unstructured":"Farquharson CA, Struthers AD (2000) Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure. Circulation 101:594\u2013597","journal-title":"Circulation"},{"key":"1048_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/diacare.19.3.257","volume":"19","author":"D Giugliano","year":"1996","unstructured":"Giugliano D, Ceriello A, Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19:257\u2013267","journal-title":"Diabetes Care"},{"key":"1048_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131\u2013138","journal-title":"Anal Biochem"},{"key":"1048_CR18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/320454a0","volume":"320","author":"RJ Gryglewski","year":"1986","unstructured":"Gryglewski RJ, Palmer RM, Moncada S (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454\u2013456","journal-title":"Nature"},{"key":"1048_CR19","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","volume":"147","author":"C Guo","year":"2006","unstructured":"Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK (2006) Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology 147:5363\u20135373","journal-title":"Endocrinology"},{"key":"1048_CR20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229\u2013234","journal-title":"N Engl J Med"},{"key":"1048_CR21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.ki.5000438","volume":"70","author":"KH Han","year":"2006","unstructured":"Han KH, Kang YS, Han SY, Jee YH, Lee MH, Han JY, Kim HK, Kim YS, Cha DR (2006) Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats. Kidney Int 70:111\u2013120","journal-title":"Kidney Int"},{"key":"1048_CR22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","volume":"96","author":"IZ Jaffe","year":"2005","unstructured":"Jaffe IZ, Mendelsohn ME (2005) Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res 96:643\u2013650","journal-title":"Circ Res"},{"key":"1048_CR23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11010-009-0178-2","volume":"332","author":"E Kazuyama","year":"2009","unstructured":"Kazuyama E, Saito M, Kinoshita Y, Satoh I, Dimitriadis F, Satoh K (2009) Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta. Mol Cell Biochem 332:95\u2013102","journal-title":"Mol Cell Biochem"},{"key":"1048_CR24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2007.06.017","volume":"572","author":"M Kushibiki","year":"2007","unstructured":"Kushibiki M, Yamada M, Oikawa K, Tomita H, Osanai T, Okumura K (2007) Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension. Eur J Pharmacol 572:182\u2013188","journal-title":"Eur J Pharmacol"},{"key":"1048_CR25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.steroids.2004.05.005","volume":"69","author":"R Losel","year":"2004","unstructured":"Losel R, Schultz A, Boldyreff B, Wehling M (2004) Rapid effects of aldosterone on vascular cells: clinical implications. Steroids 69:575\u2013578","journal-title":"Steroids"},{"key":"1048_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.phrs.2010.03.003","volume":"62","author":"T Matsumoto","year":"2010","unstructured":"Matsumoto T, Ishida K, Nakayama N, Taguchi K, Kobayashi T, Kamata K (2010) Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats. Pharmacol Res 62:271\u2013281","journal-title":"Pharmacol Res"},{"key":"1048_CR27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/nu6031236","volume":"6","author":"S Matsumoto","year":"2014","unstructured":"Matsumoto S, Gotoh N, Hishinuma S, Abe Y, Shimizu Y, Katano Y, Ishihata A (2014) The role of hypertriglyceridemia in the development of atherosclerosis and endothelial dysfunction. Nutrients 6:1236\u20131250","journal-title":"Nutrients"},{"key":"1048_CR28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bjp.0704131","volume":"133","author":"G Miric","year":"2001","unstructured":"Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L (2001) Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol 133:687\u2013694","journal-title":"Br J Pharmacol"},{"key":"1048_CR29","doi-asserted-by":"crossref","unstructured":"Mollnau H, Oleze M, Zin\u00dfius E, Hausding M, Wu Z, Knorr M, Ghaemi Kerahodi J, Kr\u00f6ller-Sch\u00f6n S, Jansen T, Teutsch C, Foster C, Li H, Wenzel P, Schulz E, M\u00fcnzel T, Daiber A (2013) Effects of telmisartan or amlodipine monotherapy versus telmisartan\/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats. Naunyn Schmiedeberg\u2019s Arch Pharmacol 386:405\u2013419","DOI":"10.1007\/s00210-013-0842-7"},{"key":"1048_CR30","doi-asserted-by":"crossref","first-page":"e93145","DOI":"10.1371\/journal.pone.0093145","volume":"9","author":"Y Nagatomo","year":"2014","unstructured":"Nagatomo Y, Meguro T, Ito H, Koide K, Anzai T, Fukuda K, Ogawa S, Yoshikawa T (2014) Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy. PLoS One 9:e93145","journal-title":"PLoS One"},{"key":"1048_CR31","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/j.1523-1755.2005.00263.x","volume":"67","author":"H Oberleithner","year":"2005","unstructured":"Oberleithner H (2005) Aldosterone makes human endothelium stiff and vulnerable. Kidney Int 67:1680\u20131682","journal-title":"Kidney Int"},{"key":"1048_CR32","doi-asserted-by":"crossref","first-page":"213176","DOI":"10.1155\/2010\/213176","volume":"2010","author":"M Oelze","year":"2010","unstructured":"Oelze M, Schuhmacher S, Daiber A (2010) Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate. Exp Diabetes Res 2010:213176","journal-title":"Exp Diabetes Res"},{"key":"1048_CR33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000320627","volume":"48","author":"M Oelze","year":"2011","unstructured":"Oelze M, Knorr M, Knorr M, Schuhmacher S, Heeren T, Otto C, Schulz E, Reifenberg K, Wenzel P, Munzel T, Daiber A (2011) Vascular dysfunction in streptozotocin-induced experimental diabetes strictly depends on insulin deficiency. J Vasc Res 48:275\u2013284","journal-title":"J Vasc Res"},{"key":"1048_CR34","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2337\/diabetes.54.8.2415","volume":"54","author":"EB Okon","year":"2005","unstructured":"Okon EB, Chung AW, Rauniyar P, Padilla E, Tejerina T, McManus BM, Luo H, van Breemen C (2005) Compromised arterial function in human type 2 diabetic patients. Diabetes 54:2415\u20132423","journal-title":"Diabetes"},{"key":"1048_CR35","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/en.2007-1476","volume":"149","author":"H Otani","year":"2008","unstructured":"Otani H, Otsuka F, Inagaki K, Suzuki J, Miyoshi T, Kano Y, Goto J, Ogura T, Makino H (2008) Aldosterone breakthrough caused by chronic blockage of angiotensin II type 1 receptors in human adrenocortical cells: possible involvement of bone morphogenetic protein-6 actions. Endocrinology 149:2816\u20132825","journal-title":"Endocrinology"},{"key":"1048_CR36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/niox.2001.0344","volume":"5","author":"S Oyadomari","year":"2001","unstructured":"Oyadomari S, Gotoh T, Aoyagi K, Araki E, Shichiri M, Mori M (2001) Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats. Nitric Oxide 5:252\u2013260","journal-title":"Nitric Oxide"},{"key":"1048_CR37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0895-7061(01)02291-9","volume":"15","author":"JB Park","year":"2002","unstructured":"Park JB, Schiffrin EL (2002) Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. Am J Hypertens 15:164\u2013169","journal-title":"Am J Hypertens"},{"key":"1048_CR38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1470320311422581","volume":"13","author":"BS Pessoa","year":"2012","unstructured":"Pessoa BS, Peixoto EB, Papadimitriou A, Lopes de Faria JM, Lopes de Faria JB (2012) Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. J Renin-Angiotensin-Aldosterone Syst 13:56\u201366","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"1048_CR39","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","volume":"105","author":"S Rajagopalan","year":"2002","unstructured":"Rajagopalan S, Duquaine D, King S, Pitt B, Patel P (2002) Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation 105:2212\u20132216","journal-title":"Circulation"},{"key":"1048_CR40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0008-6363(03)00333-X","volume":"58","author":"A Schafer","year":"2003","unstructured":"Schafer A, Fraccarollo D, Hildemann SK, Tas P, Ertl G, Bauersachs J (2003) Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction. Cardiovasc Res 58:655\u2013662","journal-title":"Cardiovasc Res"},{"key":"1048_CR41","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0735-1097(03)00845-3","volume":"42","author":"EL Schiffrin","year":"2003","unstructured":"Schiffrin EL, Touyz RM (2003) Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade. J Am Coll Cardiol 42:911\u2013913","journal-title":"J Am Coll Cardiol"},{"key":"1048_CR42","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00125-004-1525-1","volume":"47","author":"S Srinivasan","year":"2004","unstructured":"Srinivasan S, Hatley ME, Bolick DT, Palmer LA, Edelstein D, Brownlee M, Hedrick CC (2004) Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 47:1727\u20131734","journal-title":"Diabetologia"},{"key":"1048_CR43","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2337\/db12-1294","volume":"62","author":"P Sukumar","year":"2013","unstructured":"Sukumar P, Viswambharan H, Imrie H, Cubbon RM, Yuldasheva N, Gage M, Galloway S, Skromna A, Kandavelu P, Santos CX, Gatenby VK, Smith J, Beech DJ, Wheatcroft SB, Channon KM, Shah AM, Kearney MT (2013) Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes 62:2130\u20132134","journal-title":"Diabetes"},{"key":"1048_CR44","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","volume":"161","author":"Y Sun","year":"2002","unstructured":"Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT (2002) Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 161:1773\u20131781","journal-title":"Am J Pathol"},{"key":"1048_CR45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/jpet.106.106823","volume":"319","author":"HE Tawfik","year":"2006","unstructured":"Tawfik HE, El-Remessy AB, Matragoon S, Ma G, Caldwell RB, Caldwell RW (2006) Simvastatin improves diabetes-induced coronary endothelial dysfunction. J Pharmacol Exp Ther 319:386\u2013395","journal-title":"J Pharmacol Exp Ther"},{"key":"1048_CR46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2009.10.045","volume":"627","author":"A Taye","year":"2010","unstructured":"Taye A, Saad AH, Kumar AH, Morawietz H (2010) Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose. Eur J Pharmacol 627:42\u201348","journal-title":"Eur J Pharmacol"},{"key":"1048_CR47","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00210-013-0904-x","volume":"386","author":"A Taye","year":"2013","unstructured":"Taye A, Abouzied MM, Mohafez OM (2013) Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy. Naunyn Schmiedeberg\u2019s Arch Pharmacol 386:1071\u20131080","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1048_CR48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jash.2010.02.004","volume":"4","author":"CR Triggle","year":"2010","unstructured":"Triggle CR, Ding H (2010) A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS. J Am Soc Hypertens 4:102\u2013115","journal-title":"J Am Soc Hypertens"},{"key":"1048_CR49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1291\/hypres.30.439","volume":"30","author":"H Tsutsui","year":"2007","unstructured":"Tsutsui H, Matsushima S, Kinugawa S, Ide T, Inoue N, Ohta Y, Yokota T, Hamaguchi S, Sunagawa K (2007) Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Hypertens Res 30:439\u2013449","journal-title":"Hypertens Res"},{"key":"1048_CR50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.freeradbiomed.2005.03.020","volume":"39","author":"MC Wendt","year":"2005","unstructured":"Wendt MC, Daiber A, Kleschyov AL, M\u00fclsch A, Sydow K, Schulz E, Chen K, Keaney JF Jr, Lass\u00e8gue B, Walter U, Griendling KK, M\u00fcnzel T (2005) Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med 39:381\u2013391","journal-title":"Free Radic Biol Med"},{"key":"1048_CR51","doi-asserted-by":"crossref","unstructured":"Wenzel P, Schulz E, Oleze M, M\u00fcller J, Schuhmacher S, Alhamadani MS, Debrezion J, Hortmann M, Reifenberg K, Felming I, M\u00fcnzel, Daiber A (2008) AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. Free Radic Biol Med 45:619\u2013626","DOI":"10.1016\/j.freeradbiomed.2008.05.009"},{"key":"1048_CR52","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/ars.2009.2831","volume":"13","author":"WT Wong","year":"2010","unstructured":"Wong WT, Tian XY, Xu A, Ng CF, Lee HK, Chen ZY, Au CL, Yao X, Huang Y (2010) Angiotensin II type 1 receptor-dependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice. Antioxid Redox Signal 13:757\u2013768","journal-title":"Antioxid Redox Signal"},{"issue":"Suppl 2","key":"1048_CR53","first-page":"77","volume":"59","author":"O Zayachkivska","year":"2008","unstructured":"Zayachkivska O, Gzregotsky M, Ferentc M, Yaschenko A, Urbanovych A (2008) Effects of nitrosative stress and reactive oxygen-scavenging systems in esophageal physiopathy under streptozotocin-induced experimental hyperglycemia. J Physiol Pharmacol 59(Suppl 2):77\u201387","journal-title":"J Physiol Pharmacol"}],"updated-by":[{"DOI":"10.1007\/s00210-016-1237-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T00:00:00Z","timestamp":1459296000000}}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-014-1048-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-014-1048-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-014-1048-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:15:07Z","timestamp":1558628107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-014-1048-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,20]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1007\/s00210-014-1048-3","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00210-016-1237-3","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,20]]}}}